学术搜索
科研智能体
Research Labs
AI 阅读
AI 文库
AMiner 沉思
AMiner 亮点
学术资源
AI2000
期刊/会议
学者库
学术API
溯源树
数据集
知识沉淀
学术空间
订阅小程序
旧版功能
开通会员
低至0.73元/天
一次搞定AI科研
立即登录
English
联系方式
Annals of pancreatic cancer | AMiner期刊详情 | AMiner
Annals of pancreatic cancer
Journal
年发文量
研究主题
论文(285)
排序
时间
引用
1
Cluster of Differentiation 40 Agonism As a Priming Strategy in Pancreatic Ductal Adenocarcinoma: Biomarker Insights from OPTIMIZE-1
Kai-Li Liang
,
Eric S. Christenson
2026
引用
AI阅读
加入学术空间
2
Comparing Neoadjuvant Regimens in Resectable and Borderline Resectable Pancreatic Cancer: Lessons from PREOPANC-2
Maria Fernanda Teixeira
,
Pedro Luiz Serrano Uson Junior
2026
引用
AI阅读
加入学术空间
3
Perioperative Therapy to Control Hepatic Micrometastases in Pancreatic Ductal Adenocarcinoma: an Appraisal of the TOSPAC-02 Study
Omar Mahmud
,
Asad Saulat Fatimi
,
Andrew Rosowicz
,
Ammar A. Javed
2026
引用
AI阅读
加入学术空间
4
CDK4/6 Inhibition in Pancreatic Cancer: Lessons Learned As the Therapeutic Landscape Evolves
Shreyas Kalantri
,
Brandon Smaglo
2026
引用
AI阅读
加入学术空间
5
Stereotactic Body Radiotherapy in Pancreatic Ductal Adenocarcinoma: Interpreting the Results of the SPAN-C Trial
Jacobien C. M. Scheepens
,
Guus Grimbergen
,
Lois A. Daamen
2026
引用
AI阅读
加入学术空间
6
PASS-01: the Final Step on the Journey Towards the Optimal Chemotherapy Regimen for Metastatic Pancreatic Adenocarcinoma?
Victor Hugo Fonseca de Jesus
,
Alexandre Jácome
2026
引用
AI阅读
加入学术空间
7
Liquid Biopsy and Biomarkers in Pancreatic Ductal Adenocarcinoma: from Concept to Clinical Translation—a Narrative Review
Sara Mahmoud Ibrahim Allaham
,
Shamsul Mustafa Mohamed Ridha Alsaraf
,
Manal Faraj Yusuf
,
Yasamin Alsadat Sohrevardi
,
Abdifatah Fozi Hadji Abdillahi
2026
引用
AI阅读
加入学术空间
8
The Evolving Neoadjuvant Landscape in Pancreatic Cancer: Biology Often Overrides Anatomy in Achieving Margin-Negative Resection
Betty T. Chang
,
Shreeja N. Patel
,
Joseph R. Habib
,
Michael D. Kluger
2026
引用
AI阅读
加入学术空间
9
Can Preoperative Radiotherapy Reduce the Risk of Postoperative Pancreatic Fistula after Pancreatoduodenectomy?
Shahin Hajibandeh
,
Robert P. Sutcliffe
2026
引用
AI阅读
加入学术空间
10
Double Primary Biliary Malignancy: Synchronous Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma in a Whipple Specimen—a Case Report and Literature Review
Arti Agarwal
,
Manish Kumar Gupta
,
Hitesh Sarda
,
Roopak Aggarwal
,
Ekta Singh
2026
引用
AI阅读
加入学术空间
11
18F-Prostate Specific Membrane Antigen Positron Emission Tomography/computed Tomography for Pancreatic Ductal Adenocarcinoma: Not Specific Enough
Eric M. Turner
,
David S. Summerlin
,
Carli E. Calderone
,
Elainea N. Smith
,
Samuel J. Galgano
2026
引用
AI阅读
加入学术空间
12
Incremental Innovation in Endoscopic Ultrasound-Guided Biopsy: Does the Tip Make the Difference?
Sharon Pan
,
Vaibhav Wadhwa
2026
引用
AI阅读
加入学术空间
13
ATP1B1::PRKACA Fusion-Defined Intraductal Oncocytic Papillary Neoplasm of the Pancreas: a Case Report
Gregory Furletti
,
David Park
,
Kathryn LaRusso
,
Erin Meslar
,
Thomas Fishbein
,
Rashmi Samdani
2026
引用
AI阅读
加入学术空间
14
Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Adenocarcinoma: Interpreting the AGICC Study
Daire Hanna
,
David Propper
2026
引用
AI阅读
加入学术空间
15
Engineered Exosomes Silence Oncogenic KRASG12D and Awaken Immunity in Pancreatic Cancer
Raul A. Urrutia
,
Madeline Dzikowski
,
Gwen Lomberk
2026
引用
AI阅读
加入学术空间
16
Remodeling of Tumour Microenvironment of Pancreatic Cancer: Can Agonistic Anti-Cd40 Antibodies Give a New Direction?
Eric C. H. Lai
,
Aidan K. Y. Ung
2026
引用
AI阅读
加入学术空间
17
Precision Immunotherapy in Metastatic Pancreatic Cancer: OPTIMIZE-1 Biomarker-Driven Patient Stratification for Future Studies
Ahmed Abdelhakeem
,
Hani M Babiker
2026
引用
AI阅读
加入学术空间
18
Targeting Drug Efflux in Pancreatic Cancer: What the PANTAX Trial Teaches Us about Resisting Resistance
Nayef Abdel-Razeq
,
Debabrata Mukhopadhyay
,
Hani Babiker
2026
引用
AI阅读
加入学术空间
19
Defining Risk-Adapted Adjuvant Therapy in Resectable Pancreatic Cancer: an Editorial Commentary on Long-Term Outcomes from ESPAC4
Elizabeth S. Nakasone
,
Andrew L. Coveler
2026
引用
AI阅读
加入学术空间
20
ESPAC-4 Long-Term Follow-Up: Shall We Choose Gemcitabine and Capecitabine As Adjuvant Therapy for Elderly and Low-Risk Pancreatic Adenocarcinoma Following Surgical Resection?
Aaron Bertolo
,
Pamela Hodul
,
Dae Won Kim
2026
引用
AI阅读
加入学术空间
加载更多
高被引作者
作者
引用
发文
Izaak Quintus Molenaar
286
5
Burkhart Richard A
267
9
Christopher Wolfgang
256
12
Jin He
256
13
Matthew J. Weiss
253
6
John L. Cameron
234
9
Ammar A. Javed
234
8
Vincent P Groot
232
8
Yu Jun
232
7
Gemenetzis Georgios
231
7
高产作者
作者
引用
发文
Yi Miao
4
15
Kuirong Jiang
4
15
Jishu Wei
5
14
Jin He
256
13
Christopher Wolfgang
256
12
Lei Zheng
55
11
Junli Wu
4
11
Zipeng Lu
4
10
Burkhart Richard A
267
9
Wenhui Lou
0
9
相关期刊
British journal of addiction
Molecular and cellular pharmacology
Breast cancer (Dove Medical Press)
Colorectal cancer
Oncolytic virotherapy
Cancer research journal
International Journal of Hematology and Oncology
INTERNATIONAL JOURNAL of SURGERY-ONCOLOGY
Annals of Pancreatic Cancer
Immuno-Oncology and Technology